PEDF-deficient mice exhibit an enhanced rate of retinal vascular expansion and are more sensitive to hyperoxia-mediated vessel obliteration.
about
Serpins flex their muscle: I. Putting the clamps on proteolysis in diverse biological systemsPEDF and its roles in physiological and pathological conditions: implication in diabetic and hypoxia-induced angiogenic diseasesAnti-tumor effects of pigment epithelium-derived factor (PEDF): implication for cancer therapy. A mini-reviewExpression of vascular endothelial growth factor and pigment epithelial-derived factor in a rat model of retinopathy of prematurityModulation of thrombospondin 1 and pigment epithelium-derived factor levels in vitreous fluid of patients with diabetesBim is responsible for the inherent sensitivity of the developing retinal vasculature to hyperoxia.Studies on the pathogenesis of avascular retina and neovascularization into the vitreous in peripheral severe retinopathy of prematurity (an american ophthalmological society thesis)Overexpression of pigment epithelium-derived factor inhibits retinal inflammation and neovascularization.The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier--implications for the pathogenesis of diabetic retinopathy.Identification of a novel inhibitor of the canonical Wnt pathway.Pigment epithelium-derived factor mediates impaired lung vascular development in neonatal hyperoxia.Thrombospondin-2 Expression During Retinal Vascular Development and Neovascularization.Mitochondrial redox studies of oxidative stress in kidneys from diabetic mice.Pigment Epithelium-Derived Factor (PEDF) mediates cartilage matrix loss in an age-dependent manner under inflammatory conditions.Bim expression in endothelial cells and pericytes is essential for regression of the fetal ocular vasculature.The small tellurium-based compound SAS suppresses inflammation in human retinal pigment epitheliumDifferential expression of anti-angiogenic factors and guidance genes in the developing macula.Thrombospondin-1 Deficiency Exacerbates the Pathogenesis of Diabetic Retinopathy.Antiangiogenic and antineuroinflammatory effects of kallistatin through interactions with the canonical Wnt pathway.The applied biochemistry of PEDF and implications for tissue homeostasis.PEDF mediates pathological neovascularization by regulating macrophage recruitment and polarization in the mouse model of oxygen-induced retinopathy.The many facets of PEDF in drug discovery and disease: a diamond in the rough or split personality disorder?Negative regulators of angiogenesis: important targets for treatment of exudative AMD.PEDF inhibits pancreatic tumorigenesis by attenuating the fibro-inflammatory reactionIncreased angiogenic factors associated with peripheral avascular retina and intravitreous neovascularization: a model of retinopathy of prematurity.Association of retinal vascular endothelial growth factor with avascular retina in a rat model of retinopathy of prematurity.Osteogenesis imperfecta, an ever-expanding conundrum.Vitamin D receptor expression is essential during retinal vascular development and attenuation of neovascularization by 1, 25(OH)2D3.PEDF expression affects retinal endothelial cell proangiogenic properties through alterations in cell adhesive mechanisms.PEDF Expression Affects the Oxidative and Inflammatory State of Choroidal Endothelial Cells.Protease nexin-1 regulates retinal vascular development
P2860
Q24597270-5FC75E27-8C70-44EA-8B92-7B4B982E53C4Q27026916-13618F08-CDCF-42E7-AD29-0781E2020EF1Q28067001-0CF5721F-984A-4EAC-A6E9-EE4ADBED7934Q28583644-1CB12A4D-920B-46CC-B187-67BF6F0BF262Q33642146-B32B7605-F282-4579-A197-964BF8A4D07CQ33737167-1604D095-1233-4513-8EC0-6AD555623B5CQ33787955-C578EC7A-02DF-4BEB-BBE2-40946884ACBEQ33808055-BA2E0DA6-56C3-4ACD-8FE2-1205A1706C71Q34100527-8E4DA56F-9337-4D62-8777-56826422DFDBQ35096644-B700AAC8-0A2A-4C16-973B-1D3DFEB1E119Q35207704-4AD92A1C-9489-4714-B773-D4C7383F66E8Q35623995-5DBD1FBB-6D5F-4470-89A2-1F632B4FF962Q35720349-A9FB91B0-FADD-4F43-94F6-20FF7BBD2F7AQ36260387-D2BF0A98-AFBF-487D-A96D-279F89DB6DD7Q36383866-E6ED75D0-D410-4A4F-A7C8-F9D8B37D4A66Q36956642-876BE47B-BD17-4E44-B1F4-26F512A98720Q37054965-6E34BF70-7EC3-4325-B872-D3ECCC83F35DQ37283355-6CC3ED60-8B12-4BB1-930E-AC4805E75CA6Q37333523-C76DCEE9-46DA-481A-B0FA-A551AC9341C0Q37597405-AA0681DC-D982-48AE-8631-FC9550074163Q37648731-95AB31DF-2D63-4572-AB28-14807B92A130Q38103913-1A9FCE81-3AAF-431F-A02D-B3C675ED487EQ39416208-EA202844-F75F-4024-9D13-4FE624A32F5BQ41354166-6434C508-AB24-45B3-9E37-175B94A473A6Q42155672-45B7D7B1-5BCE-45F3-B8EA-7977BE3202ACQ42942158-5B554AFD-4049-4031-B51B-17A21925F464Q46031481-0D088CEE-6AF9-499C-A488-73E7C8ABBC57Q47224207-E2928B8A-B0DF-40CC-8887-2FE1EA3B3ADEQ47876851-4FD5A324-5CF4-433F-A527-70DBAEF5D0FDQ49918278-0B140981-F8D1-4259-8CDA-F20E944026F6Q58425819-6A3B2029-BCD4-49DA-A95F-033B869EBBFF
P2860
PEDF-deficient mice exhibit an enhanced rate of retinal vascular expansion and are more sensitive to hyperoxia-mediated vessel obliteration.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
PEDF-deficient mice exhibit an ...... -mediated vessel obliteration.
@en
PEDF-deficient mice exhibit an ...... -mediated vessel obliteration.
@nl
type
label
PEDF-deficient mice exhibit an ...... -mediated vessel obliteration.
@en
PEDF-deficient mice exhibit an ...... -mediated vessel obliteration.
@nl
prefLabel
PEDF-deficient mice exhibit an ...... -mediated vessel obliteration.
@en
PEDF-deficient mice exhibit an ...... -mediated vessel obliteration.
@nl
P2093
P2860
P1476
PEDF-deficient mice exhibit an ...... -mediated vessel obliteration.
@en
P2093
Christine M Sorenson
Nader Sheibani
Qiong Huang
Shoujian Wang
P2860
P304
P356
10.1016/J.EXER.2008.06.003
P577
2008-06-17T00:00:00Z